Other
parathyroid hormone
parathyroid hormone is an intervention with 6 clinical trials. Historical success rate of 100.0%.
Total Trials
6
Max Phase
—
Type
DIAGNOSTIC TEST
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 6 completed trials
Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)
Phase Distribution
Ph phase_3
2
33%
Ph phase_2
1
17%
Ph phase_4
1
17%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
6 of 6 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(6)
Detailed Status
Completed6
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (25.0%)
Phase 32 (50.0%)
Phase 41 (25.0%)
Trials by Status
completed6100%
Recent Activity
0 active trials
Showing 5 of 6
completed
Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients
NCT05275491
completed
Parathyroid Hormone Kinetics During CRRT
NCT03873675
completedphase_2
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
NCT00005006
completedphase_4
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
NCT00221299
completedphase_3
Treatment With PTH After Sternotomy in Cardiac Surgery Patients
NCT01466829
Clinical Trials (6)
Showing 6 of 6 trials
NCT05275491
Fibroblast Growth Factor 23 and Sclerostin in Relation to Calcium in COVID-19 Patients
NCT03873675
Parathyroid Hormone Kinetics During CRRT
NCT00005006Phase 2
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
NCT00221299Phase 4
Risedronate and Parathyroid Hormone to Reverse Osteoporosis Caused by Chronic Steroid Use
NCT01466829Phase 3
Treatment With PTH After Sternotomy in Cardiac Surgery Patients
NCT00000427Phase 3
Effects of Parathyroid Hormone in Men With Osteoporosis
All 6 trials loaded
Drug Details
- Intervention Type
- DIAGNOSTIC TEST
- Total Trials
- 6